Sector ratings Henan Lingrui Pharmaceutical Co., Ltd.

Equities

End-of-day quote Shanghai S.E. Other stock markets 2024-09-12			5-day change	1st Jan Change
18.79 ^CNY	-6.47%		-20.11%	+9.82%

08-12	Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
05-13	Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug	MT

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	Composite Visibility	ESG Refinitiv	Capi. ($)
HENAN LINGRUI PHARMACEUTICAL CO., LTD.			-	1.59B
DONG-E-E-JIAO CO.,LTD.			B-	4.19B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.			C+	3.52B
TASLY PHARMACEUTICAL GROUP CO., LTD			B-	2.9B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-		C	2.57B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-	-	C-	1.34B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK			-	1.32B
CRONOS GROUP INC.	-		D-	826M
TONG REN TANG TECHNOLOGIES CO. LTD.			B-	793M
BOIRON		-	B	612M
ZHEJIANG SHOUXIANGU PHARMACEUTICAL CO., LTD.		-	-	551M
Average			C+	1.84B
Weighted average by Cap.			C+